Dr. Reddy’s has been conducting small scientific trials with Sputnik V in India (File)
Bengaluru: An knowledgeable panel of India’s drug regulator on Friday sought further knowledge from drugmaker Dr.Reddy’s Laboratories on its Sputnik V COVID-19 vaccine trial, in its second such request after an preliminary analysis in February.
The committee requested the corporate to submit a comparative evaluation of late-stage immunogenicity knowledge from each its Indian research and an ongoing Russian examine, in addition to knowledge on severe opposed occasions and constructive instances reported until date.
Dr. Reddy’s has been conducting small scientific trials with Sputnik V in India underneath a take care of Russia’s wealth fund. A number of Indian firms have signed offers to supply and provide over half a billion doses of the vaccine.
(Aside from the headline, this story has not been edited by NDTV employees and is printed from a syndicated feed.)
